ReviewProstate cancer and prostatic diseases2019

Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trials.

Jose Mauricio Mota et al.PubMed ↗Publisher ↗

No numbers read from the abstract.